MedPath

Sufentanil Used by Paramedics to Treat Pain in Acute Trauma

Completed
Conditions
Trauma Injury
Pain
Interventions
Other: Sufentanil administered by paramedics based on their competency, without consultation of medical doctor.
Other: Sufentanil administered by paramedics after the phone call consultation of medical doctor.
Registration Number
NCT04913402
Lead Sponsor
Zdravotnicka Zachranna Sluzba Karlovarskeho Kraje, P.O.
Brief Summary

The new competence of paramedics to administer opioid analgesics in acute trauma patients without presence or phone-call consult with an emergency medical doctor will be assessed in this study.

Detailed Description

The administration and indication of an opioid analgesics is carried by a medical doctor in most European emergency services. However, trips to majority of less serious traumas are realized by ambulances with paramedic crews without a medical doctor present on site. In this study will be assessed the new competence of paramedics to administer opioid analgesics without presence or phone-call consult with an emergency medical doctor.

This study will address the safety and efficacy of sufentanil administered by the paramedics in the field to patients with acute trauma without any consultation with medical doctors.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
158
Inclusion Criteria
  • acute trauma with severe pain (VAS/NRS > 4)
  • age > 18 years
  • conscious patient (GCS = 15; alert in AVPU)
  • haemodynamically stable patient (> 100mmHg of systolic blood pressure, > 60/min of heart rate)
Exclusion Criteria
  • doctor on site
  • paediatric patient
  • predominantly chronic but not acute pain
  • incomplete documentation
  • other than traumatic reasons for opioid administration (eg. acute coronary syndrome)

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
CompetencySufentanil administered by paramedics based on their competency, without consultation of medical doctor.Patient who were administered sufentanil in acute trauma by paramedics with competence to administer sufentanil without any consultation with medical doctor.
ConsultationSufentanil administered by paramedics after the phone call consultation of medical doctor.Patient who were administered sufentanil in acute trauma by paramedics after phone call consultation with medical doctor.
Primary Outcome Measures
NameTimeMethod
The safety of pain treatment by the paramedics with competence to sufentanil - administration in acute trauma - incidence of bradypnoeaAfter sufentanil administration up to the handover of the patient to the hospital, up to 60 minutes.

Measurement of incidence of adverse effects of sufentanil administration in both study groups - bradypnoea - is measured during the period from sufentanil administration (baseline) up to handover of the patient to the hospital (percentage).

The safety of pain treatment by the paramedics with competence to sufentanil - administration in acute trauma - incidence of nausea.After sufentanil administration up to the handover of the patient to the hospital, up to 60 minutes.

Measurement of incidence of adverse effects of sufentanil administration in both study groups - nausea - is measured during the period from sufentanil administration (baseline) up to handover of the patient to the hospital (percentage).

The safety of pain treatment by the paramedics with competence to sufentanil - administration in acute trauma - incidence of apneaAfter sufentanil administration up to the handover of the patient to the hospital, up to 60 minutes.

Measurement of incidence of adverse effects of sufentanil administration in both study groups - apnea - during the period from sufentanil administration (baseline) up to handover of the patient to the hospital (percentage).

The efficacy of pain treatment by the paramedics with competence to sufentanil -administration in acute trauma - numeric rating scale.Before sufentanil administration and at the handover of the patient to the hospital, up to 60 minutes.

The ten point Numeric rating scale (NRS) is used to measure the efficacy of pain treatment. The difference of NRS before administration of sufentanil and at the handover at the emergency department is calculated and compared in both groups (in points).

The safety of pain treatment by the paramedics with competence to sufentanil administration in acute trauma - incidence of bradypnoea.After sufentanil administration up to the handover of the patient to the hospital, up to 60 minutes.

Measurement of incidence of adverse effects of sufentanil administration in both study groups - vomiting - is measured during the period from sufentanil administration (baseline) up to handover of the patient to the hospital (percentage).

The efficacy of pain treatment by the paramedics with competence to sufentanil - administration in acute trauma - visual analogue scale.Before sufentanil administration and at the handover of the patient to the hospital, up to 60 minutes.

The ten point Visual analogue scale is used to measure the efficacy of pain treatment. The difference of VAS before administration of sufentanil and at the handover at the emergency department is calculated and compared in both groups (in points).

Secondary Outcome Measures
NameTimeMethod
Dose of administered sufentanilAfter sufentanil administration, up to 60 minutes.

The average dose of administered sufentanil per each case (in micrograms) is reported in both groups.

Incidence of potentiation of analgesia by other analgesicsAfter sufentanil administration, up to 60 minutes.

Number of cases of potentiation of analgesia by use of additional analgesics and is reported and compared in both groups (pertcentage).

The influence on haemodynamic parameters - non invasive blood pressure (BP) -systolic blood pressureBefore sufentanil administration and at the time of the handover in hospital, up to 60 minutes.

The difference of systolic blood pressure before the administration of sufentanil and at the handover at the emergency department is measured, calculated and compared in both groups. Systolic blood pressure is measured in milimeters of hydrargyrum (mmHg).

The influence on peripheral oxygen saturation (SpO2)Before sufentanil administration and at the time of the handover in hospital, up to 60 minutes.

The difference of SpO2 before the administration of sufentanil and at the handover at the emergency department is measured, calculated and compared in both groups. SpO2 is measured as percentage.

The influence on haemodynamic parameters - non invasive blood pressure (BP) - diastolic blood pressureBefore sufentanil administration and at the time of the handover in hospital, up to 60 minutes.

The difference of diastolic blood pressure before the administration of sufentanil and at the handover at the emergency department is measured, calculated and compared in both groups. Diastolic blood pressure is measured in milimeters of hydrargyrum (mmHg).

The influence on haemodynamic parameters - heart rate (HR)Before sufentanil administration and at the time of the handover in hospital, up to 60 minutes.

The difference of heart rate before the administration of sufentanil and at the handover at the emergency department is measured, calculated and compared in both groups. Heart rate is measured as monitored or palpated beats per minute (bpm).

Types of drugs used for potentiation of analgesia by sufentanilAfter sufentanil administration, up to 60 minutes.

The type and generic name of additional analgesics and is reported and compared in both groups (pertcentage).

Need for oxygenotherapyAfter sufentanil administration up to the handover of the patient to the hospital, up to 60 minutes.

Measurement of incidence of need for oxygenotherapy is measured during the period from sufentanil administration (baseline) up to handover of the patient to the hospital (percentage).

Trial Locations

Locations (1)

Zdravotnická záchranná služba Karlovarského kraje, p.o.

🇨🇿

Karlovy Vary, Karlovarský Kraj, Czechia

© Copyright 2025. All Rights Reserved by MedPath